Progenitor Cell Therapy (United States)
- Research works
- 55 ▼ 63% vs 2013–17
- Citations
- 1.8k 33.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 26% world 28%
Not ranked overall: Progenitor Cell Therapy (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Progenitor Cell Therapy (United States)?
Ranked on the composite score, Ronald Berenson lead among researchers whose main affiliation is Progenitor Cell Therapy (United States).
- 1 Ronald Berenson United States · #1,234,046 worldwide 40 citations · 18 works
Which keywords describe research at Progenitor Cell Therapy (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Mesenchymal Stem Cells, Nanoparticles, Therapeutic Targets, Hematopoietic Stem Cells, DNA Structure, G-Quadruplexes, Self-Assembly and Bone Marrow Niche.
- Maintenance
- Attachment
- Regeneration
- Macrophages
- Cytomegalovirus
- Propolis
- Honey
- Infection
- siRNA Delivery
- Tumor Regression
- Translation
- Antioxidant
- Regulatory Challenges
- Immunotherapy
- DNA nanotechnology
- Gene Therapy
- Bone Marrow Niche
- G-Quadruplexes
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Nanoparticles
- Therapeutic Targets
- DNA Structure
- Self-Assembly
- Graft-versus-Host Disease
- Biosensors
- Inflammation
- Clinical Trials
- Stem Cell Regulation
- Ribosome
- Antiviral Therapy
- RNA Interference
- Cancer Immunotherapy
- Angiogenesis
- Mutation
- Congenital Infection
- Lymphoma
- Multipotent
- Transplant Recipients
- Integration
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Nanoparticles4▲ 5.9×6 topics
- Mesenchymal Stem Cells4▲ 61×2 topics
- Therapeutic Targets4▲ 27×2 topics
- Hematopoietic Stem Cells3▲ 56×2 topics
- DNA Structure3▲ 88×1 topic
- G-Quadruplexes3▲ 88×1 topic
- Self-Assembly3▲ 14×2 topics
- Bone Marrow Niche3▲ 158×1 topic
- Graft-versus-Host Disease3▲ 158×1 topic
- Gene Therapy3▲ 20×3 topics
- Biosensors3▲ 8.6×1 topic
- DNA nanotechnology3▲ 48×1 topic
- Inflammation2▲ 1.72×9 topics
- Immunotherapy2▲ 5.8×5 topics
- Clinical Trials2▲ 5.9×2 topics
- Regulatory Challenges2▲ 46×1 topic
- Stem Cell Regulation2▲ 159×1 topic
- Antioxidant2▲ 4.8×2 topics
- Ribosome2▲ 34×1 topic
- Translation2▲ 16×1 topic
- Antiviral Therapy2▲ 19×2 topics
- Tumor Regression2▲ 34×2 topics
- RNA Interference1▲ 22×1 topic
- siRNA Delivery1▲ 33×1 topic
- Cancer Immunotherapy1▲ 17×2 topics
- Infection1▲ 8.3×2 topics
- Angiogenesis1▲ 5.5×3 topics
- Honey1▲ 79×1 topic
- Mutation1▲ 14×2 topics
- Propolis1▲ 79×1 topic
- Congenital Infection1▲ 43×1 topic
- Cytomegalovirus1▲ 43×1 topic
- Lymphoma1▲ 13×2 topics
- Macrophages1▲ 12×3 topics
- Multipotent1▲ 50×1 topic
- Regeneration1▲ 11×1 topic
- Transplant Recipients1▲ 24×2 topics
- Attachment1▲ 15×2 topics
- Integration1▲ 15×1 topic
- Maintenance1▲ 27×1 topic
Which research topics does Progenitor Cell Therapy (United States) publish most on?
By volume in 2022–2025: Economic and Technological Innovation, Economic and Technological Developments in Russia and Economic Development and Digital Transformation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Economic and Technological Innovation Economics and Econometrics 0 works
- 2 Economic and Technological Developments in Russia Development 0 works
- 3 Economic Development and Digital Transformation General Economics, Econometrics and Finance 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Progenitor Cell Therapy (United States)'s research output changed?
Output in 2018–2022 was 63% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.